Abstract:BACKGROUND Prohibitin 1 (PHB1) has been identified as an antiproliferative protein that is highly conserved and ubiquitously expressed, and it participates in a variety of essential cellular functions, including apoptosis, cell cycle regulation, proliferation, and survival. Emerging evidence indicates that PHB1 may play an important role in the progression of hepatocellular carcinoma (HCC). However, the role of PHB1 in HCC is controversial. AIM To investigate the effects of PHB1 on the proliferation and apoptosis of human HCC cells and the relevant mechanisms in vitro . METHODS HCC patients and healthy individuals were enrolled in this study according to the inclusion and exclusion criteria; then, PHB1 levels in the sera and liver tissues of these participates were determined using ELISA, RT-PCR, and immunohistochemistry. Human HepG2 and SMMC-7721 cells were transfected with the pEGFP-PHB1 plasmid and PHB1-specific shRNA (shRNA-PHB1) for 24-72 h. Cell proliferation was analysed with an MTT assay. Cell cycle progression and apoptosis were analysed using flow cytometry (FACS). The mRNA and protein expression levels of the cell cycle-related molecules p21, Cyclin A2, Cyclin E1, and CDK2 and the cell apoptosis-related molecules cytochrome C (Cyt C), p53, Bcl-2, Bax, caspase 3, and caspase 9 were measured by real-time PCR and Western blot, respectively. RESULTS Decreased levels of PHB1 were found in the sera and liver tissues of HCC patients compared to those of healthy individuals, and decreased PHB1 was positively correlated with low differentiation, TNM stage III-IV, and alpha-fetoprotein ≥ 400 μg/L. Overexpression of PHB1 significantly inhibited human HCC cell proliferation in a time-dependent manner. FACS revealed that the overexpression of PHB1 arrested HCC cells in the G0/G1 phase of the cell cycle and induced apoptosis. The proportion of cells in the G0/G1 phase was significantly increased and the proportion of cells in the S phase was decreased in HepG2 cells that were transfected with pEGFP-PHB1 compared with untreated control and empty vector-transfected cells. The percentage of apoptotic HepG2 cells that were transfected with pEGFP-PHB1 was 15.41% ± 1.06%, which was significantly greater than that of apoptotic control cells (3.65% ± 0.85%, P < 0.01) and empty vector-transfected cells (4.21% ± 0.52%, P < 0.01). Similar results were obtained with SMMC-7721 cells. Furthermore, the mRNA and protein expression levels of p53, p21, Bax, caspase 3, and caspase 9 were increased while the mRNA and protein expression levels of Cyclin A2, Cyclin E1, CDK2, and Bcl-2 were decreased when PHB1 was overexpressed in human HCC cells. However, when PHB1 was upregulated in human HCC cells, Cyt C expression levels were increased in the cytosol and decreased in the mitochondria, which indicated that Cyt C had been released into the cytosol. Conversely, these effects were reversed when PHB1 was knocked down. CONCLUSION PHB1 inhibits human HCC cell viability by arresting the cell cycle and inducing cell apoptosis via activation of the p53-mediated mitochondrial pathway.

Overexpression of Integrin Β1 Inhibits Proliferation of Hepatocellular Carcinoma Cell SMMC‐7721 Through Preventing Skp2‐dependent Degradation of P27 Via PI3K Pathway

STAT1 Inhibits Human Hepatocellular Carcinoma Cell Growth Through Induction of P53 and Fbxw7

CHI3L1 Promotes Tumor Progression by Activating TGF-β Signaling Pathway in Hepatocellular Carcinoma.

S-Phase Delay in Human Hepatocellular Carcinoma Cells Induced by Overexpression of Integrin Beta 1

Mechanism of Pi3k Signaling-Mediated Hepatoma Cell Growth Involves P27 and Skp2, but Akt Independent

Increased Integrin Alpha5beta1 Heterodimer Formation and Reduced C-Jun Expression Are Involved in Integrin Beta1 Overexpression-Mediated Cell Growth Arrest.

Over Expression of Integrin Α 5 Β 1 in Human Hepatocellular Carcinoma Cell Line Suppresses Cell Proliferation in Vitro and Tumorigenicity in Nude Mice

Over-expression of P27kip1 Affects Cell Cycle of Hepatocellular Carcinoma Cell Lines

Increased Expression of Integrin Β1 Subunit Enhances P21waf1/cip1 Transcription Through the Sp1 Sites and P300‐mediated Histone Acetylation in Human Hepatocellular Carcinoma Cells

Influence of Over- Expressing Protein Kinase B on Proliferation and Apoptosis of Human Hepatocellular Carcinoma SMMC 7721 Cells

Prohibitin 1 inhibits cell proliferation and induces apoptosis via the p53-mediated mitochondrial pathway in vitro

Overexpression of B7-H1 correlates with malignant cell proliferation in pancreatic cancer.

Silencing of the S-Phase Kinase-Associated Protein 2 Gene (SKP2) Inhibits Proliferation and Migration of Hepatocellular Carcinoma Cells

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Overexpression of P27(Kip1) Induced Cell Cycle Arrest in G(1) Phase and Subsequent Apoptosis in Hcc-9204 Cell Line

Effect of P27(Kip1) on Cell Cycle and Apoptosis in Gastric Cancer Cells

Over-expression of P27~(kip1) Threonine Residue 187 Mutant Type Gene Induces G_(0) Phase Arrest in HepG_(2) Cell Lines

Expression and Relationship of p27kip1 and Spy1 During the Proliferation Process of Hepatocellular Carcinoma Cell HuH7

PD-L1 intrinsically promotes the proliferation of breast cancer cells through the SKP2-p27/p21 axis

Down-regulation of Mirna-196B Expression Inhibits the Proliferation, Migration and Invasiveness of HepG2 Cells While Promoting Their Apoptosis Via the PI3K/Akt Signaling Pathway.

Lkb1 Inhibits Breast Cancer Partially Through Repressing The Hedgehog Signaling Pathway